S 5167
TEST Act of 2022
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
The TEST Act of 2022 extends the temporary scheduling of fentanyl-related substances for two years. It requires the Drug Enforcement Administration to submit synthetic fentanyl compounds to the Food and Drug Administration for evaluation, and it establishes a process for potentially removing fentanyl-related substances from schedule I if they demonstrate a lower potential for abuse. The bill also aims to ensure that individuals impacted by prosecution related to these substances are notified of any scheduling changes.
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.